Stock Ratings / Health Care / BKD / options

MD (76) SGRY (66) NHC (73) ARDT (69) ⌘ Pro Terminal →

Brookdale Senior Living Inc. (BKD) Options Positioning, Max Pain & Unusual Sweeps

$10.39 +1.17% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $10.39

Brookdale Senior Living Inc. (BKD) carries a Roarable Rating of E (Strong Sell) with 31/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record Warning: Scores below 50 (31/100 · E) historically underperformed SPY in 71% of rolling 90-day windows →

ROARABLE E • RED ALERT Cap $2.45B

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on BKD Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is BKD stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-02, Brookdale Senior Living Inc. (NYSE: BKD) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 31/100 at a spot price of $10.39 (+1.17% 1D, market cap $2.45B). Pillar breakdown: Fundamental Cash Engine 9/20, Institutional 13F & Options Flow 6/20, Executive Insider Alignment 5/20, FRED Macro Regime Fit 6/20, and SEC Balance-Sheet Forensics 5/20. Across 1016 tracked Health Care issuers, BKD ranks #797 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does BKD compare to MD and SGRY in the Health Care sector?

▼

Within the Health Care sector (Hospital/Nursing Management), BKD carries a Roarable E (31/100 RQD), trailing P/E of N/A, gross margin of 26.2%, and ROIC of 0.3%. By comparison, MD (Pediatrix Medical Group Inc.) holds a B+ grade (76/100 RQD, P/E 14.3x, ROIC 33.6%, cap $2.37B) and SGRY (Surgery Partners Inc.) posts a C+ grade (66/100 RQD, P/E N/A, ROIC 9.9%, cap $3.04B). Among the 5-stock peer group, ARDT leads on earnings multiple (12.8x) while MD leads on capital efficiency (33.6% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for BKD?

▼

Per BKD's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001332349), Brookdale Senior Living Inc. generated $3.19B in revenue (+2.2% YoY), -$262.7M in net income, and $16.5M in free cash flow against $5.95B in total assets and $4.22B in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $10.39 (+0.02%)🧬 Dilution Drag (+1.92% YoY Shares)⚙️ Cash Engine: 9/20 (D) • 0.5% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record Warning: Scores below 50 (31/100 · E) historically underperformed SPY in 71% of rolling 90-day windows (-9.4% avg 90D alpha vs SPY • 29.0% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERRED ALERT • E

3-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw E · Rk E

Each axis scored 0–20

12M PRICE TARGET CONE-12.1% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for BKD)Realized 20D OHLCV Swing Band: ±7.1%

Deterministic 5-Pillar Attribution (31/100 Composite)

🔍 WHY BKD SCORES 31/100 (E) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Cash Engine Quality+9/20 pts (29% of score)

SEC XBRL FY 2025 (10-K): 0.5% FCF Margin ($16.5M FCF) & 26.2% Gross Margin

▲ #2 Bullish Driver: Whale & Options Positioning+6/20 pts (19% of score)

20D Institutional Volume Accumulation (±7.1% realized swing band)

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution5/20 pts (-15 pt drag)

Dilution Drag (+1.92% YoY Shares) & executive Form 4 sales trim 15 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade E$10.24-3.7% Next Q

Q2 (-2Q)

Grade E$9.86-1% Next Q

Q3 (-1Q)

Grade E$9.76+6.5% Next Q

Current

Grade E$10.39-9.4% Hist 90D α

Trajectory: E (23) → E (31)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a BKD Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While BKD currently carries a cautious 31/100 (E) rating due to Insider Conviction & Share Dilution (5/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Health Care with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($11.03) and Max Pain ($10.91) forces dealer call-delta covering toward $17.94.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Dilution Drag (+1.92% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $BKD• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “BKD Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 31%NO 69%Trade / Inspect Odds →

CALL VS. PUT WHALE SHARE

— (No Active Options Snapshot)

Put/Call Ratio: — (No Active Options Snapshot)

MAX-PAIN EXPIRATION MAGNET

— (No Active Options Snapshot)

No active options chain max-pain snapshot on file

HISTORICAL 20D VOLATILITY SWING

±7.1%

Derived from 20D OHLCV bars (No Active Options Snapshot)

Active Strike Call vs. Put Concentration Ladder (BKD)

— (No Active Options Snapshot) — No unusual CBOE strike concentration anomalies recorded in the current database snapshot for BKD.

Sponsored / Partner SpotlightACTIVE TRADER & PROP EVALUATION DESK

Practice in Our Weekly $100,000 Paper Arena Before Risking Personal Capital

Keep your personal nest egg in cash while trading NQ, ES, Crude, and Gold momentum using institutional prop-desk buying power.

FTC Disclosure: Roarable may receive partner referral compensation at no cost to you. Partner relationships never influence RQD scores.

🏆 Enter Free $100K Paper Arena →

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring BKD)

✓Walkthrough of BKD's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

BKD // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -25.89%▲ RESISTANCE BREAKOUT

2026-11-02O $9.98H $10.39L $9.98C $10.39VOL 4.21M

RES: $10.19SUP: $8.68SMA50: $11.03SMA200: $13.32

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

BKD Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 BKD Butterfly Map → + Track BKD →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

32.5%/yr Implied 5Y Growth

vs. +2.2% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on BKD today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for BKD. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for BKD today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (BKD)

Health Care Rank #797 of 1016 ⚔️ MD vs BKD Full Matrix →

1. Head-to-Head Health Care Peer Comparison (BKD vs. MD, SGRY, NHC, ARDT)

Industry: Hospital/Nursing Management (14 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Brookdale Senior Living Inc. (BKD) ranks #797 by composite RQD confidence (31/100, grade E) and #223 by equity capitalization ($2.45B). Within this direct 5-issuer industry benchmark cohort, ARDT leads on earnings valuation at 12.8x trailing P/E, while MD leads on capital efficiency and profitability with 33.6% ROIC and — gross margin. MD currently holds the highest overall quantitative score in the immediate peer group at 76/100 (B+) compared with BKD at 31/100 (E).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
BKD ACTIVE Brookdale Senior Living Inc.	E	31/100	—	26.2%	0.3%	+1.17%	$2.45B	Benchmark Subject
MD Pediatrix Medical Group Inc.	B+	76/100	14.3x	—	33.6%	+2.19%	$2.37B	/md-vs-bkd →
SGRY Surgery Partners Inc.	C+	66/100	—	—	9.9%	0.00%	$3.04B	/sgry-vs-bkd →
NHC National HealthCare Corporation	B	73/100	27.7x	—	10.1%	-2.84%	$3.32B	/nhc-vs-bkd →
ARDT Ardent Health Inc.	C+	69/100	12.8x	—	10.5%	-2.19%	$1.73B	/ardt-vs-bkd →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001332349

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Brookdale Senior Living Inc. (BKD) reported GAAP revenue of $3.19B (+2.2% vs. FY2024 revenue of $3.13B , and +5.9% cumulative change since FY2023) , GAAP net income of -$262.7M, operating cash flow of $218.0M, and free cash flow of $16.5M (+147.1% YoY). On the balance sheet, BKD closed FY2025 with $5.95B in total assets against $4.22B in total debt (Altman Z-Score: 0.20, Piotroski F-Score: 4/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$3.19B	-$262.7M	$218.0M	$16.5M	$5.95B	$4.22B
FY2024 (FY)	2024-12-31	$3.13B	-$201.9M	$166.2M	-$35.1M	$6.34B	$4.02B
FY2023 (FY)	2023-12-31	$3.02B	-$189.0M	$162.9M	$162.9M	—	—

3. BKD Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is BKD stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does BKD compare to MD and SGRY in the Health Care sector?

What are the biggest fundamental strengths and SEC risk factors for BKD?

Where is BKD trading relative to its 50-day, 200-day, and 52-week technical levels?

BKD last traded at $10.39 (+1.17% on volume of 5,487,423 shares), positioning the stock -5.80% below its 50-day simple moving average ($11.03) and -22.00% below its 200-day simple moving average ($13.32). Across its 52-week range of $8.02 to $17.09, BKD sits at the 26.1% percentile with a 14-day RSI of 46.0 (NEUTRAL RANGE) and an implied next-earnings move of ±7.1% ($9.65 to $11.13).

BKD Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

What is BKD's options positioning and volatility profile?

Roarable tracks verified CBOE unusual options sweeps, put/call ratios, and OHLCV realized volatility bands for BKD.

Direct Sub-Reports: BKD RQD Cockpit BKD 12M Forecast BKD Earnings & Move BKD Dividends & DRIP BKD Insiders & 13F BKD Whale Options BKD Profit Sankey BKD News & Why

Sector Peer Dials

Compare →

MD B+

Pediatrix Medical Group Inc.

76 /100

SGRY C+

Surgery Partners Inc.

66 /100

NHC B

National HealthCare Corporation

Healthcare Services Group Inc.

73 /100

SNDA E

Sonida Senior Living Inc.

31 /100

BKD Core Snapshot

Market Cap $2.45B

Trailing / Fwd P/E — / —

Gross Profit Margin 26.2%

Return on Capital (ROIC) 0.3%

Free Cash Flow Yield 0.67%

12M Base Price Target $9.13

FREE TRADER TOOLS

Own BKD Alongside Other Stocks? Run a 30-Second Crash X-Ray

Drop 3–5 tickers into our live Portfolio X-Ray to spot hidden accounting time-bombs and see your composite RQD dial.

⚡ X-Ray My Portfolio With BKD → 🏆 Trade BKD in $100K Prop Arena →

BKD Wire

Why It Moved →

Direct Company Event Yahoo! Finance Canada • 7h ago

Brookdale Senior Living Inc. (BKD) Stock Price, News, Quote & History

Direct Company Event Yahoo Finance • 10h ago

Brookdale Senior Living (BKD) Tests Its Valuation On Stronger Occupancy Results

Direct Company Event MarketBeat • 13h ago

Brookdale Senior Living (BKD) Stock Price, News & Analysis $BKD

Peer / Ecosystem Wire TradingView • 16h ago

Brookdale Announces Third Quarter 2026 Earnings Release and Conference Call

Peer / Ecosystem Wire PR Newswire • 19h ago

Brookdale Reports September 2026 Occupancy

ROARABLE RATING BRIEF • RQD 31/100 (E) ✓ STAGE-C NUMBER FIREWALL VERIFIED

BKD — Brookdale Senior Living Inc.: What the Facts Mean to a Prospective Investor

Engine: anthropic/claude-haiku-5.5

As of: 2026-11-02T15:25:39Z

Roarable Rating Brief: What This Means to a Prospective Investor

The Roarable RQD score for BKD is 31 out of 100, graded E, with the verdict "Roarable Strong Sell — Forensic Risk / Avoid" (per the Roarable RQD rating). The five pillars are each scored out of 20:

Fundamental Cash Engine: 9 / 20. The pillar cites ROIC of 0.3% and FCF yield of 0.67% (per the Roarable RQD rating and market data). Returns on invested capital are close to zero, so the business is generating little economic profit on the capital it employs. For an investor, this means the cash-generation case is weak, and any valuation rests more on recovery expectations than on current earnings power.
Whale / 13F Flow: 6 / 20. The pillar is labeled as institutional accumulation and options positioning (per the Roarable RQD rating). No holder-level detail is provided in the source data, so the score cannot be traced to specific positions. Investors should treat this as a modest signal, not a confirmed institutional endorsement.
Insider Conviction: 5 / 20. The pillar references SEC Form 4 and Congressional PTR cluster flow (per the Roarable RQD rating). The underlying transactions are not itemized in the source data. A low insider score suggests insiders are not signaling strong conviction in the shares.
Macro Regime Fit: 6 / 20. The pillar cites a beta of 1.0 and sector sensitivity (per the Roarable RQD rating and market data). A beta of 1.0 means the stock is expected to move in line with the broad market, so it does not offer a defensive profile on this measure, and its sector exposure adds a layer of regime risk.
Forensic Balance Sheet: 5 / 20. The pillar cites Altman Z of 0.2, Piotroski F of 4/9, and Debt/Equity of 0.5 (per the Roarable RQD rating). An Altman Z of 0.2 is the weakest forensic input in the set and signals elevated financial distress risk; this is the pillar most responsible for the forensic-risk verdict.

Taken together, the composite points to a stock where the upside case depends on a turnaround in profitability and cash conversion that the current numbers do not yet show. Valuation tradeoffs are significant: EV/EBITDA of 34.6 (per market data) is high relative to the thin operating margin and near-zero ROIC, so a prospective investor is paying for improvement that has not yet arrived. The main upside driver would be sustained operating-margin and cash-flow improvement; the main downside is that the balance sheet has limited room to absorb further weakness.

Financial Trend

Period	Revenue	Operating Income	Net Income	EPS	FCF	Cash	Debt
FY 2025	$3194.1M	$13.5M	$-262.7M	N/A	$16.5M	$279.1M	$4215.0M
FY 2024	$3125.5M	$46.5M	$-201.9M	N/A	$-35.1M	$308.9M	$4022.0M
FY 2023	$3015.8M	$18.4M	$-189.0M	N/A	$162.9M	N/A	N/A

Per the SEC financials, revenue rose across the three reported periods, but net income was negative in every period, and FY 2025 net income of $-262.7M was larger in magnitude than FY 2024's $-201.9M. Market data show a gross margin of 26.2%, operating margin of 0.4%, and net margin of -8.2%, with ROIC of 0.3%. The Altman Z-Score is 0.2 and the Piotroski F-Score is 4/9 (per the Roarable RQD rating), both weak readings. Debt of $4215.0M against cash of $279.1M (FY 2025) indicates a leveraged balance sheet, with Debt/Equity of 0.5 (per the Roarable RQD rating).

Recent Catalysts & News Wire Analysis

Per the recent news feed, the headlines reference the following items, all tagged YELLOW with MARKET WIRE impact:

A headline on Brookdale's stock price and market action (Yahoo! Finance Canada, 1h ago).
A headline linking the valuation to occupancy results (Yahoo Finance, 3h ago).
A MarketBeat stock-analysis item (6h ago).
An announcement of a third-quarter 2026 earnings release and conference call (TradingView, 9h ago).
A PR Newswire release on September 2026 occupancy (12h ago).
A headline stating the stock slid as occupancy recovery showed signs of slowing (Timothy Sykes, 15h ago).

The occupancy theme recurs across the items and the most recent negative headline points to slowing recovery, which is a risk watch item. Per the Butterfly Supply-Chain Graph, the supply chain is listed as NONE, with no butterfly links and no proprietary signals.

Open Questions

What is the company's EPS (TTM) and forward earnings path, given that P/E and EPS are unavailable in the source data?
What drove the increase in net loss from $-201.9M (FY 2024) to $-262.7M (FY 2025) despite revenue growth?
What is the trend and level of occupancy, and does the September 2026 occupancy release confirm or contradict the "slowing recovery" headline?
What is the composition of the $4215.0M debt, including maturities and refinancing needs against $279.1M of cash?
Which institutions and insiders hold or trade the stock, and at what size and timing, given that holder data is absent?

BKD Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Brookdale Senior Living Inc. (BKD) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to BKD Debate Forum (3) ↓

🟡 MARKET WIRE Yahoo! Finance Canada • 7h ago

Brookdale Senior Living Inc. (BKD) Stock Price, News, Quote & History

Yahoo! Finance Canada report covering Brookdale Senior Living Inc. (BKD) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Yahoo Finance • 10h ago

Brookdale Senior Living (BKD) Tests Its Valuation On Stronger Occupancy Results

Yahoo Finance report covering Brookdale Senior Living Inc. (BKD) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE MarketBeat • 13h ago

Brookdale Senior Living (BKD) Stock Price, News & Analysis $BKD

MarketBeat report covering Brookdale Senior Living Inc. (BKD) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE TradingView • 16h ago

Brookdale Announces Third Quarter 2026 Earnings Release and Conference Call

TradingView report covering Brookdale Senior Living Inc. (BKD) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE PR Newswire • 19h ago

Brookdale Reports September 2026 Occupancy

PR Newswire report covering Brookdale Senior Living Inc. (BKD) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Timothy Sykes • 22h ago

BKD Stock Slides As Occupancy Recovery Shows Signs Of Slowing

Timothy Sykes report covering Brookdale Senior Living Inc. (BKD) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE StockStory • 1d ago

1 safe-and-steady stock to own for decades and 2 we question

StockStory report covering Brookdale Senior Living Inc. (BKD) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Yahoo Finance • 1d ago

Brookdale Senior Living (BKD): Favorable Senior Housing Demographics Reaffirm Long-Term Thesis

Yahoo Finance report covering Brookdale Senior Living Inc. (BKD) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

BKD Bull vs. Bear Conversation Board — What's Your Call at $10.39?

🐂 33% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON BKD 🐻 67% BEARISH CONVICTION

RO RoarDesk_Moderator Roarable Research Desk 🐻 BEARISH 🎯 Target: $9.04 (-12.0%)

📌 Pinned Debate

🔥 Official Bull vs. Bear Debate: Is BKD (E • RQD 31/100) a Buy at $10.27?

Welcome to the BKD (Brookdale Senior Living Inc.) Roar Pit. Current RQD Composite is 31/100 (Roarable Strong Sell — Forensic Risk / Avoid) in Hospital/Nursing Management. Bulls point to operating leverage and sector positioning, while bears focus on macro rate sensitivity and margin execution. Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.

RE RedlineAuditor Forensic Accounting Watch 🐻 BEARISH 🎯 Target: $7.81 (-24.0%)

Spot @ $10.27

Pump the brakes on BKD — check the valuation vs. margin headwinds

Everyone in here is repeating the bull case on BKD, but look at what you are paying: current EV/EBITDA multiples with 26.2% gross margins. Unless Brookdale Senior Living Inc. expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.

AL AlphaFlow_Cap Verified K Arena Trader 🐂 BULLISH 🎯 Target: $13.04 (+27.0%)

Spot @ $10.27

BKD cash flow & RQD setup is being underpriced by the Street here

Looking at the 5-pillar RQD breakdown on BKD, the market is fixating on short-term headline noise in Hospital/Nursing Management and ignoring the balance sheet and cash flow trajectory. At $10.27 (52-wk range $8.02 - $17.09), any beat on forward guidance forces shorts and underweight funds to chase.